Deadline: 30 Nov 2027
Germany
Ref. No.: 23087241
EMD:Ref Document
Bid Value: Ref Document
507 Days Left
Deadline: 22 Dec 2026
United States
Ref. No.: 23086864
EMD:Ref Document
Bid Value: Ref Document
164 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23085491
EMD:Ref Document
Bid Value: Ref Document
507 Days Left
Open House Drug Discount Agreements For The Active Ingredient Denosumab Trade Name Xgeva Atc M05Bx04
Deadline: 30 Apr 2027
Germany
Ref. No.: 23085170
EMD:Ref Document
Bid Value: Ref Document
293 Days Left
Deadline: 29 Dec 2028
Australia
Ref. No.: 23084881
EMD:Ref Document
Bid Value: Ref Document
902 Days Left
Deadline: 27 Jun 2027
Sweden
Ref. No.: 23082850
EMD:Ref Document
Bid Value: Ref Document
351 Days Left
Deadline: 24 Dec 2026
United States
Ref. No.: 23082420
EMD:Ref Document
Bid Value: Ref Document
166 Days Left
Deadline: 09 Dec 2026
United States
Ref. No.: 23082321
EMD:Ref Document
Bid Value: Ref Document
151 Days Left
Deadline: 30 Jun 2028
United Kingdom
Ref. No.: 23082288
EMD:Ref Document
Bid Value: Ref Document
720 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23082183
EMD:Ref Document
Bid Value: Ref Document
507 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23082139
EMD:Ref Document
Bid Value: Ref Document
507 Days Left
Deadline: 30 Nov 2027
Germany
Ref. No.: 23081911
EMD:Ref Document
Bid Value: Ref Document
507 Days Left
Deadline: 31 Aug 2027
United Kingdom
Ref. No.: 23081779
EMD:Ref Document
Bid Value: Ref Document
416 Days Left
Deadline: 14 Sep 2027
United Kingdom
Ref. No.: 23081557
EMD:Ref Document
Bid Value: Ref Document
430 Days Left
Deadline: 31 Jul 2026
United Kingdom
Ref. No.: 23081553
EMD:Ref Document
Bid Value: Ref Document
20 Days Left